Royal Philips (NYSE:PHG) said today that it launched its IntraSight interventional lab applications platform designed to provide clinically proven iFR, FFR, IVUS and co-registration modalities intended to simplify complex interventions and hasten routine procedures.
The IntraSight platform features a touchscreen control, systems integration, data management and remote service diagnostics, the Amsterdam-based company said.
Philips said that the newly launched IntraSight platform is intended for use with the company’s Azurion image-guided therapy platform, and that together the systems can improve cardiac and peripheral vascular patient’s care.
“IntraSight has made an immediate impact in our lab. It is so simple and intuitive to use that it took us no time at all to get used to it. It has made using physiology and imaging even quicker and easier, which is a great advance for us and for our patients,” Dr. Rasha Al-Lamee of London’s Imperial College Healthcare NHS Trust said in a press release.
The IntraSight platform also features the company’s SyncVision to allow for mapping both a patient’s pressure profile and IVUS measurements onto an angiogram for improved identification of locations causing ischemia, planning of stent length and placement and predicting physiological improvements.
“The range and complexity of cardiovascular diseases that can be treated with minimally invasive procedures continues to expand. Correspondingly, the procedures themselves are also becoming more complex, increasing the demands on physicians to integrate different sources of information, decide on the best course of treatment for each patient, act on that decision and confirm the treatment’s effectiveness. IntraSight is an important step forward in integrating intravascular diagnostic applications into a smart, simple and seamless workflow in the interventional lab,” Philips image guided therapy chief biz leader Bert van Meurs said in a prepared statement.
Earlier this month, Philips said that it inked a 10-year strategic partnership deal with Rutherford Diagnostics to offer advanced diagnostics services across the UK.